RBOT
RBOT
NYSE · Health Care

Vicarious Surgical Inc-A

$0.60
+0.05 (+9.09%)
As of May 16, 2:28 AM ET ·
Financial Highlights (FY 2026)
Revenue
16.75M
Net Income
-76,201,352
Gross Margin
9.0%
Profit Margin
-455.0%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 9.0% 64.2% 64.2% 64.2%
Operating Margin -483.8% 5.6% 5.4% 5.4%
Profit Margin -455.0% 5.9% 5.7% 5.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 16.75M 5.87M 5.46M 4.72M
Gross Profit 1.51M 3.77M 3.51M 3.03M
Operating Income -81,038,540 328.5K 297.2K 253.2K
Net Income -76,201,352 346.6K 311.4K 267.2K
Gross Margin 9.0% 64.2% 64.2% 64.2%
Operating Margin -483.8% 5.6% 5.4% 5.4%
Profit Margin -455.0% 5.9% 5.7% 5.7%
Rev Growth -7.7% +9.5% +17.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 4.78M 5.18M 3.90M
Total Equity 6.42M 6.36M 7.03M
D/E Ratio 0.74 0.81 0.56
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -77,627,620 517.9K 465.4K 439.0K
Free Cash Flow 320.8K 267.0K 264.5K